Certificate of Advanced Studies in Lung cancer - second cohort (CASLu2)
24.03.2021 - 26.05.2022
APPLICATION CLOSED
POSTGRADUATE PROGRAMME
Block 3
15.07.2021 - 15.10.2021
CASLu2: Module 2: Principles of lung cancer research
Programme
15 July | ||
| Principles of basic research Samra Turajlic, UK | ||
| Principles of translational research Christian Britschgi, CH | ||
| Biobanking Mitchell Levesque, CH | ||
| Principles of phase 1, 2, 3 clinical trials Urania Dafni, GR | ||
| Statistical Principles: Evaluating Clinical Trials and Research Projects Urania Dafni, GR | ||
| Design and conduct of clinical trials Anouk Neven, BE | ||
| Good clinical practice Anita Hiltbrunner, CH | ||
| Valid end-points of clinical trials Enriqueta Felip, ES | ||
| Interpretation of clinical trial results Jean-Paul Sculier, BE | ||
| ESMO magnitude of clinical benefit scale Urania Dafni, GR | ||
| Legal requirements and frameworks for pre-clinical and clinical research Anastassia Negrouk, BE | ||
| Lung cancer research organisations and societies Rolf A. Stahel, CH | ||
Faculty
Christian Britschgi, University Hospital Zurich, Dept. of Haematology and Oncology, Zurich, CH
Urania Dafni, National and Kapodistrian University of Athens, Public Health Dpt., Goudi-Athens, GR
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, ES
Anita Hiltbrunner, IBCSG/ETOP, Director, Bern, CH
Mitchell Levesque, University of Zurich Hospital, Faculty of Medicine, Dept. of Dermatology, Schlieren, CH
Anastassia Negrouk, EORTC DPO, International Policy Office, Brussels, BE
Anouk Neven, EORTC Headquarters, Statistics Department, Brussels, BE
Jean-Paul Sculier, Institut Jules Bordet, Dept. of Thoracic Oncology, Brussels, BE
Rolf A. Stahel, University Hospital Zurich, Comprehensive Cancer Center Zurich, Zurich, CH
Samra Turajlic, The Francis Crick Institute, Turajlic Lab, London, UK